Until Aperiomics’ service was launched, detection of pathogens that cause infection was a hit-and-miss process that left patients and clinicians frustrated. Too often, people were sick for months or years before their clinicians could make accurate diagnoses and begin the healing process. This was highly challenging for medical professionals and often heartbreaking for patients and their families. More than 75% of infections in the U.S. go undetected and millions of dollars are spent each year by patients on testing that too often completely fails patients.
Aperiomics is the only company of its kind and scope in the world. We are revolutionizing the way that medical professionals around the world identify infections. Supported by the National Science Foundation, Aperiomics identifies every known, sequenced bacteria, virus, fungus, and parasite through deep shotgun metagenomic sequencing, using our world renown database containing over 37,000 microbes. We help doctors identify the cause of infections that other tests cannot identify. Many patients that we have helped were sick for years with no understanding of why. Patients and their physicians often contact Aperiomics after hearing how we have helped others. Aperiomics was named Life Science Innovator of the Year in 2016 and International Start Up of the Year in 2018.
Aperiomics is upending everything about the way in which infections are identified, completely changing the thinking about pathogen testing. Armed with brilliant ideas to fill a huge gap in medical testing and a mission to help those in need, the company launched in 2014.